Health X Platform (BOM:533259) Cyclically Adjusted Revenue per Share: ₹262.31 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533259 Health X Platform Ltd BOM:533259
69 GF Score
Price ₹288.00
GF Value ₹394.15
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Health X Platform Cyclically Adjusted Revenue per Share?

Health X Platform BOM:533259 -1.44% 69 Cyclically Adjusted Revenue per Share is ₹262.31 as of Jun. 2026. GuruFocus rates BOM:533259 with a GF Score™ of 69/100 and a GF Value™ of ₹394.15 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Health X Platform's adjusted revenue per share for the three months ended in Jun. 2026 was ₹138.726. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹262.31 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Health X Platform's average Cyclically Adjusted Revenue Growth Rate was 24.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 28.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 31.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Health X Platform was 35.80% per year. The lowest was 28.00% per year. And the median was 34.60% per year.

As of today (2026-08-19), Health X Platform's current stock price is ₹288.00. Health X Platform's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹262.31. Health X Platform's Cyclically Adjusted PS Ratio of today is 1.10.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Health X Platform was 7.14. The lowest was 1.10. And the median was 2.09.


Health X Platform  (BOM:533259) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Health X Platform's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=288.00/262.31
=1.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Health X Platform was 7.14. The lowest was 1.10. And the median was 2.09.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Health X Platform Cyclically Adjusted Revenue per Share Related Terms


Health X Platform Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Health X Platform's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health X Platform Cyclically Adjusted Revenue per Share Chart

Health X Platform Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.88 117.00 163.13 199.75 245.28

Health X Platform Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 210.38 222.41 233.20 245.28 262.31

Health X Platform Cyclically Adjusted Revenue per Share Competitor Comparison

For the Pharmaceutical Retailers subindustry, Health X Platform's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health X Platform Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health X Platform's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Health X Platform's Cyclically Adjusted PS Ratio falls into.


BOM:533259
69GF Score
Health X Platform Ltd BOM:533259
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Health X Platform Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Health X Platform's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=138.726/167.3573*167.3573
=138.726

Current CPI (Jun. 2026) = 167.3573.

Health X Platform Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 11.847 105.961 18.711
201612 9.989 105.196 15.892
201703 10.832 105.196 17.233
201706 12.071 107.109 18.861
201709 11.263 109.021 17.290
201712 13.717 109.404 20.983
201803 14.653 109.786 22.337
201806 15.622 111.317 23.487
201809 17.056 115.142 24.791
201812 17.318 115.142 25.171
201903 18.643 118.202 26.396
201906 23.271 120.880 32.219
201909 29.066 123.175 39.492
201912 32.351 126.235 42.890
202003 36.483 124.705 48.961
202006 41.991 127.000 55.335
202009 43.844 130.118 56.392
202012 42.851 130.889 54.790
202103 42.388 131.771 53.836
202106 53.317 134.084 66.548
202109 49.663 135.847 61.183
202112 45.010 138.161 54.522
202203 49.947 138.822 60.214
202206 60.353 142.347 70.957
202209 79.646 144.661 92.142
202212 88.093 145.763 101.144
202303 97.032 146.865 110.571
202306 103.659 150.280 115.438
202309 113.552 151.492 125.444
202312 110.692 152.924 121.139
202403 95.298 153.035 104.217
202406 82.716 155.789 88.858
202409 83.032 157.882 88.015
202412 88.085 158.323 93.111
202503 88.734 157.552 94.257
202506 87.663 159.755 91.835
202509 97.126 162.289 100.159
202512 105.808 163.281 108.450
202603 118.881 164.272 121.113
202606 138.726 167.357 138.726

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹262.31 mean?
Health X Platform (BOM:533259) has a Cyclically Adjusted Revenue per Share of ₹262.31 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Health X Platform and its competitors.
Is Health X Platform's Cyclically Adjusted Revenue per Share too high?
Health X Platform's current Cyclically Adjusted Revenue per Share is ₹262.31. Overall, Health X Platform has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Health X Platform's Cyclically Adjusted Revenue per Share compare to competitors?
Health X Platform's Cyclically Adjusted Revenue per Share of ₹262.31 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Health X Platform and its competitors. Health X Platform's current Cyclically Adjusted Revenue per Share is ₹262.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health X Platform stock overvalued right now?
Based on GuruFocus' analysis, Health X Platform (BOM:533259) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹394.15, compared to a current price of ₹288.00 — trading 26.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹262.31. Health X Platform's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Health X Platform (BOM:533259), the current Cyclically Adjusted Revenue per Share is ₹262.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Health X Platform (BOM:533259) Overvalued in 2026?

Based on GuruFocus' analysis, Health X Platform stock appears to be undervalued. The current stock price of ₹288.00 is trading 26.9% below its estimated GF Value™ of ₹394.15. GuruFocus considers Health X Platform to be Modestly Undervalued.

Key valuation signals for BOM:533259:

  • Cyclically Adjusted Revenue per Share: ₹262.31
  • GF Value™: ₹394.15 vs. price of ₹288.00 (26.9% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the BOM:533259 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Health X Platform Business Description

Other Exchanges HEALTHX:India
Address 7 Abanindra Nath Thakur Sarani, Azimganj House, 2nd Floor, Kolkata, WB, IND, 700017
Health X Platform Ltd, formerly Sastasundar Ventures Ltd is a Core Investment Company. Through its subsidiaries, the company is focused on the business of digital network of healthcare and portfolio management services. Its business segments are; Financial Services, and Healthcare Network. The majority of its revenue is generated from the Healthcare Network segment which includes activities for pathology and marketing of healthcare and OTC products through e-commerce portal and diagnostic services which consist of pathological/radiological investigations. Geographically, the company operates only in India.
69GF Score

Get the complete analysis for BOM:533259

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹288.00
Price
₹394.15
GF Value